Substantial developments have occurred in the past 5–10 years in clinical translational
research of thyroid cancer. Diagnostic molecular markers, such as RET-PTC, RAS, and …

The incidence of differentiated thyroid cancer is increasing greatly in high-income countries.
Roughly 50% of this increase is attributable to the identification of intrathyroidal papillary …

Importance Thyroid cancer is the most pervasive endocrine cancer worldwide. Studies
examining the association between thyroid cancer and country, sex, age, sociodemographic …

Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Background: Thyroid cancer (TC) incidence is rising in many countries, but the
corresponding mortality is constant or declining. Incidence increases appear largely …

A thyroid incidentaloma is an unexpected, asymptomatic thyroid tumor fortuitously
discovered during the investigation of an unrelated condition. The prevalence rate is 67 …

The widespread use of ultrasonography places it in a key position for use in the risk
stratification of thyroid nodules. The French proposal is a five-tier system, our version of a …

Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …

Background: Papillary thyroid cancer (PTC) is the most common subtype of thyroid cancer,
and inflammation relates significantly to its initiation and prognosis. Systematic exploration …

Background Microwave ablation (MWA) and radiofrequency ablation (RFA) have recently
attracted interest as minimally invasive treatment modalities for papillary thyroid carcinoma …